Form EFFECT Nasus Pharma Ltd
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 13, 2026 4:30 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
- Volta Peptides Wins Research Peptide Supplier of the Year 2026 Award from Peptide Atlas
- vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share